Charter Medical Launches New High Yield Single-Use Cell Culture Bags
Charter Medical, Ltd., a division of Lydall, Inc., (NYSE:LDL) today announced the launch of Bio-Pak® Cell Culture bags for biotech and pharmaceutical processing. These bags are designed to provide a stable cell culture environment to enhance cell growth and viability. They are made from Charter’s high performance Clear-Pak® film, a single web, multi-layer film with superior gas barrier properties. The Bio-Pak® Cell Culture bags are offered in several sizes and configurations which can be customized to meet manufacturers’ needs. This line will be produced on new equipment in Charter’s recently expanded ISO Class 7 Clean Room.
Peter Ferris, President of Charter Medical, stated, “This new product offering is a perfect fit for our Life Sciences growth initiative as it rounds out our Bio-Pak® line in an exciting space. The biotech single-use market continues to grow at double-digit rates and the cell culture bag is a key product targeted with our recent capital investments. Bio-Pak® Cell Culture bags join Charter’s other new Bio-Pak® products, the 3D Gusset and Small Volume single-use systems, which together offer a comprehensive solution ranging in size from 50 milliliters to 3500 liters.”
“This new product is designed to improve cell culture yields and increase throughput, saving our customers both time and money,” remarked Joe Petrosky, Global VP of Sales and Marketing for Charter Medical. “This is an exciting time for Charter Medical. With the launch of the Bio-Pak® Cell Culture bag, we clearly demonstrate our commitment to flexibility, speed and operational excellence.”
Lydall, Inc. is a New York Stock Exchange listed company, headquartered in Manchester, Connecticut. The Company, with operations in the U.S., The Netherlands, France, and Germany and sales offices in Europe and Asia, focuses on specialty engineered products for the thermal/acoustical and filtration/separation markets. Charter Medical, Ltd., a Lydall subsidiary, is a vital fluids management company focused on providing products to separate, contain and transport vital fluids in the blood and cell therapy market and the biotech and pharmaceutical industries. Lydall® is a registered trademark of Lydall, Inc. in the U.S. and other countries. All product names are trademarks of Lydall, Inc. or Charter Medical, Ltd.
Charter Medical, Ltd. headquarters and ISO 13485 registered manufacturing facility are located in Winston-Salem, North Carolina. Learn more about Charter Medical at www.chartermedical.com.